Exome Sequencing Revealed Notch Ligand JAG1 As a Novel Candidate Gene for Familial Exudative Vitreoretinopathy

Lin Zhang,Xiang Zhang,Huijuan Xu,Lulin Huang,Shanshan Zhang,Wenjing Liu,Yeming Yang,Ping Fei,Shujin Li,Mu Yang,Peiquan Zhao,Xianjun Zhu,Zhenglin Yang
DOI: https://doi.org/10.1038/s41436-019-0571-5
IF: 8.864
2020-01-01
Genetics in Medicine
Abstract:Purpose Familial exudative vitreoretinopathy (FEVR) is a blindness-causing retinal vascular disease characterized by incomplete vascularization of the peripheral retina and by the absence or abnormality of the second/tertiary capillary layers in the deep retina. Variants in known FEVR disease genes can only explain about 50% of FEVR-affected cases. We aim to identify additional disease genes in patients with FEVR. Methods We applied exome sequencing analysis in a cohort of 49 FEVR families without pathogenic variants in known FEVR genes. Functions of the affected proteins were evaluated by reporter assay. Knockout mouse models were generated by endothelial-specific Cre line. Results Three novel rare heterozygous variants in Notch ligand JAG1 were identified in FEVR families—c.413C>T p. (A138V), c.1415G>A p. (R472H), and c.2884A>G p. (T962A)—and verified by Sanger sequencing analysis. Notch reporter assay revealed that mutant JAG1 proteins JAG1-A138V and JAG1-T962A lost almost all of their activities, and JAG1-R472H lost approximately 50% of its activity. Deletion of Jag1 in mouse endothelial cells resulted in reduced tip cells at the angiogenic front and retarded vessel growth, reproducing FEVR-like phenotypes. Conclusion Our data suggest that JAG1 is a novel candidate gene for FEVR and pinpoints a potential target for therapeutic intervention.
What problem does this paper attempt to address?